Klenk Jeffrey P. 4

What Happened
Jeffrey P. Klenk, Executive Vice President and President, Bond & Specialty Insurance at Travelers Companies (TRV), was granted 12,854 shares as an award/derivative acquisition on February 3, 2026. The shares were recorded at $0.00 acquisition price (code A — award/grant). This is a company compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-03; Form 4 filed: 2026-02-05 (filed within the typical 2-business-day reporting window).
• Transaction type/code: Award/Grant (A); derivative security reported.
• Shares granted: 12,854; acquisition price reported as $0.00.
• Shares owned after transaction: not specified in the summary provided — see the full Form 4 for post-transaction holdings.
• Footnotes/conditions: filing summary provided does not list 10b5-1 plan or tax-withholding details; awards often have vesting conditions (check the full filing for vesting/tax notes).

Context
An "award" reported at $0.00 typically reflects compensation—such as restricted stock units or performance shares—that may vest over time or on performance conditions, not an immediate market purchase. Such grants are routine components of executive pay and do not by themselves indicate buying/selling intent. For full details (vesting schedule, plan name, and post-transaction holdings), consult the complete Form 4 filing.